Search

Displaying results 8331 - 8340 of 10000 in total
  1. Drug

    Xanoxic acid

    go.drugbank.com/drugs/DB21173
    Experimental

    Xanoxic acid has a monoisotopic molecular weight of 298.08 Da.

  2. Drug

    Tizoprolic acid

    go.drugbank.com/drugs/DB21293
    Experimental

    Tizoprolic acid has a monoisotopic molecular weight of 171.04 Da.

  3. Drug

    Hydroxytoluic acid

    go.drugbank.com/drugs/DB21441
    Experimental

    Hydroxytoluic acid has a monoisotopic molecular weight of 152.05 Da.

    Synonyms: O-cresotic acid, Cresotic acid, o-
  4. Drug

    Bimatoprost grenod

    go.drugbank.com/drugs/DB21634
    Experimental

    Bimatoprost grenod has a monoisotopic molecular weight of 574.33 Da.

  5. Drug

    Pregabalin naproxencarbil

    go.drugbank.com/drugs/DB21744
    Experimental

    Pregabalin naproxencarbil has a monoisotopic molecular weight of 459.23 Da.

  6. Drug

    Itopride

    go.drugbank.com/drugs/DB04924
    Investigational

    Itopride is a dopamine D2 antagonist with acetylcholinesterase inhibitory actions.

    Products: DOIZ 50 MG FC TABLET, Itomed 50 mg Filmtabletten
  7. Drug

    Ginsenoside Rb1

    go.drugbank.com/drugs/DB06749
    ExperimentalNutraceutical

    Ginsenosides have been the target of research, as they are viewed as the active compounds behind the claims of ginseng's efficacy. … Ginsenosides are a class of steroid glycosides, and triterpene saponins, found exclusively in the plant genus Panax (ginseng).

  8. Drug

    Alphameprodine

    go.drugbank.com/drugs/DB01499
    ExperimentalIllicit

    Alphameprodine is a structural analogue of meperidine. … Alphameprodine is an opioid analgesic classified by the United States Drug Enforcement Administration under Schedule I of illegal substances.

  9. Drug

    Betameprodine

    go.drugbank.com/drugs/DB01552
    ExperimentalIllicit

    Betameprodine is a structural analogue of meperidine. … Betameprodine is an opioid analgesic classified by the United States Drug Enforcement Administration under Schedule I of illegal substances.

  10. Drug

    ChulaCov19 mRNA vaccine

    go.drugbank.com/drugs/DB16445
    Experimental

    The next phase of this study is for phase I and II clinical trials (NCT04566276) beginning in January 2021. … Pre-clinical studies in mice and monkeys showed evidence that the vaccine facilitates an impressive generation of neutralizing antibodies[L30678].